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Monoaminergic	 descending	 pathways	 contribute	 to	 modulation	 of	




























on	 noradrenergic	 (NE)	 and	 serotonergic	 (5HT)	 modulation	 of	 neuropathic	 pain.	
Following	 sciatic	 nerve	 transection	 and	 repair	 (SNTR)	 rats	 developed	 significant	





raphe	 magnus	 (RM)	 and	 dorsal	 raphe	 nucleus	 (DRN),	 with	 a	 pattern	 suggesting	
reorganization	of	serotonergic	excitatory	interconnections	between	PAG	and	DRN.	iTR	
also	 increased	 the	 expression	 of	 α1A	 in	 locus	 coeruleus	 (LC)	 and	 DRN,	 and	 β2	 in	 LC,	
indicating	that	exercise	enhanced	activity	of	NE	neurons,	likely	by	activating	autologous	
projections	from	DRN	and	PAG.		
iTR	 hypoalgesia	 was	 antagonized	 by	 blockade	 of	 β2	 and	 5HT2A	 receptors	 with	
administration	 of	 butoxamine	 and	 ketanserin.	 The	 neurotoxin	 DSP4	 was	 injected	 to	
induce	 depletion	 of	 NE	 projections	 from	 LC	 before	 starting	 iTR.	 DSP4	 treatment	
worsened	 mechanical	 hyperalgesia,	 but	 iTR	 hypoalgesia	 was	 similarly	 produced.	
Moreover,	5HT2A	expression	in	LC	further	increased	after	DSP4	injection,	all	these	results	
suggesting	 an	 intrinsic	 regulation	 of	 5HT	 and	NE	 activity	 between	 PAG,	 DRN	 and	 LC	
neurons	activated	by	iTR.		
Finally,	 iTR	 significantly	 reduced	 microglial	 reactivity	 in	 LC	 and	 increased	 non-
























al.,	 2013,	 Lopez-Alvarez	 et	 al.,	 2015).	 iTR-induced	 decrease	 of	 BDNF	 expression	was	
associated	 to	 reduction	 of	microgliosis	 and	 restoration	 of	 the	 expression	 of	 chloride	




Brain	 areas	 can	 modulate	 the	 ascending	 pain	 signals	 by	 serotonergic	 and	
noradrenergic	 projections	 to	 spinal	 cord	 neurons,	 which	 can	 facilitate	 or	 inhibit	 the	
afferent	 sensory	 neurons.	 Periaqueductal	 grey	 (PAG)	 areas	 receive	 pain	 and	
temperature	 fibers	 and	 activate	 defensive	 and	 stress	 responses	 by	 sending	 axons	 to	
both	 locus	 coeruleus	 (LC)	 and	 raphe	 magnus	 nucleus	 (RM),	 whose	 antinociceptive	
output	trigger	descending	inhibition	(Millan,	2002).	Serotonergic	RM	and	noradrenergic	
LC	 projections	 normally	 activate	 spinal	 enkephalinergic	 and	 GABA/glycinergic	
interneurons.	 Enkephalin	 released	 from	 terminals	 of	 enkephalinergic	 dorsal	 horn	
interneurons	 acts	 on	 the	 opioid	 receptors	 located	 on	 the	 central	 processes	 of	
nociceptive	primary	afferents,	reducing	Ca2+	entry	into	their	terminals	and	decreasing	
the	 release	 of	 nociceptive	 neurotransmitters	 such	 as	 glutamate	 and	 substance	 P	
(Ossipov	et	al.,	2010).	Similarly,	activation	of	dorsal	horn	interneurons	containing	GABA	
or	glycine	also	inhibit	the	spinal	transmission	of	noxious	sensory	signals,	and	previous	
studies	 indicate	 that	 spinal	GABAergic	 inhibition	 is	 reduced	after	experimental	nerve	
injury	 (Moore	et	al.,	 2002).	The	 loss	of	 tonic	 inhibition	by	 spinal	 interneurons	 is	also	
associated	 with	 dysregulation	 of	 NKCC1/KCC2	 chloride	 cotransporters	 expression,	
inducing	 an	 inversion	 of	 GABAergic	 depolarizing	 currents	 in	 neuropathic	 conditions	
(Modol	et	al.,	2014),	that	is	prevented	by	iTR	(Lopez-Alvarez	et	al.,	2015).		
Besides	the	demonstrated	peripheral	effects	(Cobianchi	et	al.,	2010,	2013;	Lopez-
Alvarez	et	 al.,	 2015;	Udina	et	al.,	 2011),	we	hypothesized	 that	 iTR	may	activate	pain	
central	 inhibition	normally	gating	the	nociceptive	input	to	supraspinal,	medullary	and	
cortical	 areas,	which	 are	 decreased	 after	 peripheral	 nerve	 injury.	 By	 stimulating	 the	













expressed	 in	 dorsal	 horn	 neurons	 (Nicholson	 et	 al.,	 2005),	 which	 activation	 induces	
antinociceptive	effects	(Yalcin	et	al.,	2009a,b,	2010;	Zhang	et	al.,	2016).	We	also	assessed	







In	 this	 study,	we	 investigated	 the	 changes	 induced	by	 iTR	on	noradrenergic	 and	
serotonergic	 circuitry	 that	 may	 be	 related	 to	 antinociception.	 For	 this	 purpose,	 we	
analyzed	the	expression	of	adrenergic	α1A,	α2A	and	β2	receptors,	and	serotonergic	5HT2A	
receptor	after	 injury	 to	 the	 sciatic	nerve	 in	 rats,	 and	 their	 changes	under	 increasing-








access	 to	 food	 and	 water	 ad	 libitum	 under	 a	 light–dark	 cycle	 of	 12	 hours.	 All	 the	
experimental	 procedures	were	 approved	by	 the	 Ethics	 Committee	of	 the	Universitat	
Autonoma	de	Barcelona	and	followed	the	guidelines	of	the	European	Commission	on	
Animal	Care	(EU	Directive	2010/63/EU).	Rats	were	anesthetized	by	intraperitoneal	(i.p.)	
injection	 of	 ketamine	 (10	 mg/kg,	 Imalgene	 500;	 Rhone-Merieux,	 Lyon,	 France)	 and	
xylazine	(1	mg/kg,	Rompun;	Bayer,	Leverkusen,	Germany).		
Rats	 were	 submitted	 to	 a	 sciatic	 nerve	 transection	 and	 repair	 (SNTR),	 a	 well	
characterized	 model	 that	 allows	 the	 evaluation	 of	 neuropathic	 pain	 and	 nerve	
regeneration	 (Cobianchi	et	al.,	2014).	The	right	sciatic	nerve	was	exposed	at	 the	mid	
thigh,	 transected	 at	 92	mm	 from	 the	 tip	 of	 the	 third	 toe,	 and	 repaired	by	 epineural	




Seven	days	before	 surgery,	 all	 the	animals	were	habituated	 to	 the	experimental	













group,	n=10),	and	a	 second	group	 remained	sedentary	 (SNTR-sed	group,	n=8).	Other	
groups	 performed	 or	 not	 iTR	 with	 pharmacological	 blockade	 of	 β2-receptors	 with	
butoxamine	(Sigma-Aldrich,	8	mg/Kg	in	saline,	i.p.;	SNTR-iTR+Bu	group,	n=6,	and	SNTR-
sed+Bu	group,	n=6),	or	blockade	of	5HT2A-receptors	with	ketanserin	(Sigma-Aldrich,	8	
mg/Kg	 in	 saline,	 i.p.;	 SNTR-sed+Ke	 group,	 n=6,	 and	 SNTR-iTR+Ke	 group,	 n=6).	 These	
drugs	were	administered	each	day	of	training,	30	minutes	before	starting	the	exercise.	
Doses	were	chosen	over	the	basis	of	previous	studies	using	rats.	Control	groups	for	both	











Three	 days	 before	 surgery,	 all	 the	 injured	 animals	 were	 habituated	 to	 the	




were	 tested	 to	 differentiate	 changes	 in	 sensory	 thresholds	 produced	 respectively	 by	





























hours	 respectively,	 and	 then	 cryoprotected	 with	 30%	 sucrose	 in	 PBS.	 Transverse	
sections,	 25	µm	 thick,	were	 cut	on	a	 cryostat	 and	mounted	on	 slides.	 Sections	were	
blocked	with	specific	serum	and	incubated	overnight	with	primary	antibodies	in	0.3%	
Triton	X-100	 in	PBS,	used	 for	 staining	5HT	and	NE	 receptors	 in	 spinal	 cord	and	brain	
sections	 (anti-β2	 receptors,	 rabbit,	 1:500,	 Santa	Cruz;	 anti-α1A	receptors,	 goat,	 1:500,	
Santa	Cruz;	anti-α2A	receptors,	goat,	1:500,	Santa	Cruz;	anti-5HT2A	receptors,	goat,	1:500,	





Alexa	 Fluor	 594	 conjugated	 secondary	 antibodies	 (1:200,	 Life	 Technologies).	 After	
washing	in	PBS,	sections	were	coverslipped	with	a	solution	of	DAPI	(1	mL/mL)	in	Mowiol	

















made	 by	 two-way	 analysis	 of	 variance	 (ANOVA)	with	 group	 and	 time	 after	 injury	 as	
factors,	 followed	 by	 Bonferroni’s	 post	 hoc	 comparisons.	 Statistical	 comparisons	 for	
immunofluorescence	data	were	made	by	one-way	and	two-way	ANOVAs	followed	by	







hindpaw	 to	 monitor	 the	 contribution	 to	 hyperalgesia	 of	 collateral	 sprouting	 of	
saphenous	nerve,	and	of	denervation	by	the	injured	sciatic	nerve	(Cobianchi	et	al.,	2013;	
Lopez-Alvarez	et	al.,	2015).	As	showed	in	Fig.	1A-B,	mechanical	and	thermal	thresholds	
in	 uninjured	 contralateral	 paws	 were	 not	 significantly	 affected	 by	 injury	 with	 an	
ipsi/contra%	threshold	ratio	of	about	100%	at	3	dpi.	However	SNTR	produced	a	marked	
decrease	of	the	mean	mechanical	threshold	at	the	medial	side	from	3	to	14	dpi	(Fig.	1A;	
48	 to	32%	of	contralateral	 in	SNTR-sed	group).	The	decrease	of	 thermal	 threshold	at	
medial	side	was	comparatively	lower	(Fig.	1B;	92	to	69%	in	SNTR-sed	group).	Statistical	
analyses	for	both	group	and	time	factors,	and	also	their	interaction,	showed	significant	
effects	 for	 the	changes	observed	 in	mean	medial	mechanical	 (Group	 factor:	F=26.39,	
p<0.0001;	Time	factor:	F=71.45,	p<0.0001;	Interaction:	F=9.35,	p<0.0001)	and	thermal	
thresholds	 (Group	 factor:	 F=17,	 p=0.0001;	 Time	 factor:	 F=4,	 p<0.0114;	 Interaction:	






















(Fig.	 3A).	 SNTR	 reduced	 the	 expression	 of	 β2	 receptor	 in	 both	 the	 ipsilateral	 and	
























stronger	 staining	was	 observed	 in	 the	DRN	 after	 injury	 (Fig.	 5B,	 SNTR-sed	 group),	 in	
contrast	with	the	reduced	expression	in	the	dorsal	horn.	iTR	significantly	increased	α1A	
immunoreactivity	 in	 LC	 and	 DRN,	 and	 in	 adjacent	 areas,	 such	 as	 the	 subcoeruleus	










and	 RM	 of	 naïve	 rats	 (Fig.	 6A,	 naïve	 group).	 Nerve	 injury	 did	 not	 induce	 significant	
changes	in	β2	receptors	(Fig.	6A,	SNTR-sed	group).	iTR	rats	showed	immunoreactivity	in	
a	larger	area	of	LC	(Fig.	6A-B,	SNTR-iTR	vs.	SNTR-sed	p<0.01;	SNTR-iTR	vs.	naïve	p<0.05),	




and	DRN	 regions	 and	 rarely	 in	 the	 RM	nucleus	 extending	 laterally	 into	 the	 adjacent	

















of	 β2	 receptors	with	 butoxamine,	 a	 selective	 β2	 blocker,	 before	 starting	 iTR	 sessions	






SNTR-iTR	 vs.	 SNTR-iTR+Ke,	 p<0.001	 at	 14	 dpi).	 Ketanserin	 treatment	 alone	 partially	









from	 the	 LC	 (Grzanna	 et	 al.,	 1989),	 thus	 preventing	 the	 activation	 of	NE	 descending	
projections	during	iTR	(Fig.	9).	In	rats	receiving	DSP4	injection	the	hyperalgesia	was	even	
slightly	 increased	 compared	 with	 untreated	 rats	 (Fig.	 9A).	 However,	 iTR	 treatment	
similarly	 produced	 hypoalgesia	 in	 injured	 rats	 (p<0.01	 SNTR-iTR+DSP4	 vs.	 SNTR-
sed+DSP4),	despite	the	depletion	of	NE	output	significantly	reduced	the	expression	of	
β2	and	α1A	receptors	in	the	LC,	which	was	not	compensated	by	iTR	(Fig.	9B-C).	This	result	























in	 the	 pathway	 that	 leads	 to	 BDNF	 regulation	 and	 KCC2	 dephosphorylation	 in	
neuropathic	pain	states	(Modol	et	al.,	2014),	we	evaluated	the	microglial	activation	after	




immunoreactivity	 (p<0.05,	 SNTR-sed	 vs.	 SNTR-iTR).	 However,	 the	 effect	 of	 iTR	 was	
reverted	by	butoxamine	injection	(p<0.001,	naïve	vs.	SNTR-sed+Bu	and	SNTR-iTR+Bu).	




show	 that	 β2	 receptors	 are	 involved	 in	 the	 iTR	 reduction	of	microglial	 reaction	 after	




et	 al.,	 2013;	 Lopez-Alvarez	 et	 al.,	 2015;	 Udina	 et	 al.,	 2011),	 we	 also	 analyzed	 BDNF	
expression	 in	 the	 LC.	 BDNF	 immunoreactivity	was	 scant	 in	 LC	 of	 naïve	 rats,	 and	 not	



















the	 contribution	 of	 α1	 receptors	 to	 antinociception	 by	 activation	 of	 GABAergic	 and	
glycinergic	inhibitory	interneurons.	Our	results	suggest	that	the	downregulation	of	α1A	






dendrites	 of	 superficial	 dorsal	 horn	 neurons	 (Nicholson	 et	 al.,	 2005;	 Patterson	 and	
Hanley,	1987;	Mizukami,	2004).	Interestingly	capsaicin	treatment	in	rats	decreased	the	
β	adrenergic	binding	sites	in	the	spinal	cord	(Patterson	and	Hanley,	1987),	as	we	have	









potential	 in	 the	 hyperpolarizing	 direction	 (Bos	 et	 al.,	 2013),	 restoring	 endogenous	








On	 the	 other	 hand,	 we	 showed	 that	 immunoreactivity	 to	 5HT2A	 after	 SNTR	
significantly	decreased	 in	 laminae	I-III,	similarly	to	β2	receptor,	and	the	prevention	of	
5HT2A	receptor	activation	during	exercise	by	pretreatment	with	ketanserin	reduced	the	
iTR	hypoalgesic	 effect.	 Then	 if	 restoration	of	both	 spinal	 5HT2A	 and	β2	 receptors	 is	 a	
direct	consequence	of	iTR,	5HT2A	may	be	not	directly	involved	as	β2	in	the	mechanism	of	
early	pain	suppression.	This	may	be	explained	by	the	multiple	roles	that	5HT2A	receptor	
may	 play	 on	 neuropathic	 pain	 conditions,	 by	 differently	 acting	 on	 neuronal	
subpopulations	of	dorsal	horn	to	inhibit	or	facilitate	pain	signals.	After	injury,	a	shift	of	
5HT2A	 receptors	 to	 inhibitory	 interneurons	 was	 shown	 (Aira	 et	 al.,	 2010).	 Since	 iTR	
counteracted	 the	 spinal	 loss	 of	 5HT2A,	 we	 suggest	 that	 our	 treadmill	 protocol	 may	
potentiate	the	activity	of	inhibitory	interneurons	that	intervene	in	nociception.		
Besides	 changes	 in	 the	 spinal	 cord,	 antinociception	may	 be	 conveyed	 by	 iTR	 by	
activation	of	 5HT2A	 receptor	 as	well	 as	 adrenoreceptors	 at	higher	brain	 centers.	 It	 is	
known	that	projections	from	PAG-RM	and	LC	to	the	spinal	cord	play	a	pivotal	role	in	pain	
control.	Pain	and	temperature	fibers	project	to	PAG	through	the	spinomesencephalic	
tract,	 and	PAG	 can	 control	 afferent	pain	by	means	of	 parallel	 actions	on	RM	and	 LC	
(Basbaum	 and	 Fields,	 1978).	 In	 these	 nuclei,	 antinociceptive	 mechanisms	 can	 be	
activated	through	μ1	opioid,	5HT2A	and	5HT2C	serotonergic,	and	α1A	adrenergic	receptors	
of	 the	 LC	 (de	 Freitas	 et	 al.,	 2016).	 β2	 receptor	 is	 also	 expressed	 in	 areas	 directly	
participating	in	pain	(Nicholson	et	al.,	2005),	and	human	genetic	studies	confirmed	the	
contribution	 of	 β2	 to	 chronic	 pain	 disorders	 (Diatchenko	 et	 al.,	 2006).	Moreover,	 β2	
receptor	is	essential	for	the	antiallodynic	action	of	antidepressant	drugs	(Yalcin	et	al.,	
2009a,b),	 since	 the	 absence	 or	 blockade	 of	 β2	 suppressed	 the	 hypoalgesic	 effect	 of	
antidepressant	drugs	on	mechanical	allodynia	(Yalcin	et	al.,	2009b).		
The	actions	played	by	iTR	on	mesencephalic	nuclei	to	activate	central	pain	control	
may	 be	 multiple,	 and	 conveyed	 through	 synaptic	 regulation	 of	 NE	 and	 5HT	










exercise	 increases	 the	 release	 of	 5HT	 in	 supraspinal	 areas	 associated	 to	 reducing	
mechanical	hyperalgesia	(Gerin	et	al.,	2008;	Korb	et	al.,	2010;	Jacobs	et	al.,	2002).	In	a	
recent	 work,	 Bobinski	 et	 al.	 (2015)	 found	 increased	 brainstem	 levels	 of	 5HT,	 its	
metabolites	and	5HT1B/2A/2C	 receptors	after	a	2-weeks	 low-intensity	 treadmill	 training	
following	 sciatic	 nerve	 injury.	 Interestingly,	 the	 inhibition	 of	 5HT	 but	 not	 of	
catecholamines	 reversed	 the	 hypoalgesic	 effect	 of	 such	 low-intensity	 exercise.	 At	
difference,	 our	 study	 suggests	 that	 NE	 antinociception	 can	 be	 further	 activated	 by	
increasing	the	intensity	of	exercise.	Indeed,	the	iTR	training	induced	an	increase	of	α1A,	
β2	and	5HT2A	receptors	expression	in	the	PAG-DRN	and	PAG-LC	pathways.	5HT	and	NE	
systems	may	 interact	 in	 these	areas	during	exercise.	Earlier	 studies	 revealed	 that	NE	




descending	 pain-suppressing	 neurons.	 NE	 axons	 could	 also	 activate	 α1	 receptors	 on	
GABAergic	 and	 glycinergic	 inhibitory	 interneurons	 leading	 to	 inhibition	 of	 pain-relay	
neurons	(Pertovaara,	2006).	












receptor	 activity	 in	 the	 brainstem.	 Our	 results	 highlight	 the	 5HT	 and	 NE	 reciprocal	
actions	under	neuropathic	pain	and	blockade	of	NE	neurons.		
Brain	and	spinal	expression	of	neurotrophins,	particularly	BDNF,	can	be	modulated	
by	 activation	 of	 NE	 and	 5HT	 pathways,	 with	 relevant	 effects	 on	motor	 and	 sensory	




blockade	 significantly	 attenuates	 the	 increase	 of	 BDNF	mRNA	due	 to	 exercise	 in	 the	
cortex	(Ivy	et	al.,	2003).	On	the	other	hand,	BDNF	released	by	activated	microglia	triggers	
neuropathic	mechanisms,	such	as	downregulation	of	chloride	cotransporter	KCC2	(Coull	
et	 al.,	 2005;	 Ferrini	 and	 De	 Koninck,	 2013),	 associated	 to	 disinhibition	 at	 spinal	
interneurons	(Modol	et	al.,	2014).	iTR	increased	the	BDNF	expression	in	LC	parallel	to	















inhibition,	 by	 increasing	 activity	 of	 serotonergic	 and	 noradrenergic	 projections	 from	
brainstem	 centers,	 to	 the	 beneficial	 effects	 of	 specific	 exercise	 training	 programs	 in	
reducing	 neuropathic	 pain.	 Future	 studies	 aimed	 at	 understanding	 which	 neuronal	
populations	 and	which	molecular	mechanisms	underlying	 pain	 inhibition	 and	 central	
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2016.	 Stimulation	 of	 spinal	 dorsal	 horn	 beta2-adrenergic	 receptor	 ameliorates	 neuropathic	


























Figure	 1.	Hyperalgesia	 is	 reduced	 by	 iTR	 after	 SNTR.	 Changes	 in	mechanical	 (A)	 and	













at	 14	 dpi	 in	 the	 spinal	 dorsal	 horn	 of	 naïve	 rats,	 and	 in	 the	 ipsilateral	 (ipsi)	 and	








































(A)	Graphic	 representation	 of	 PAG,	 RM,	DRN	 and	 LC	 nuclei	 considered	 as	 regions	 of	
interest	for	quantification	in	coronal	sections.	(B)	Representative	confocal	images	of	the	
5HT2A	serotonergic	receptor	immunoreactivity	at	14	dpi	in	PAG,	DRN	and	RM	of	naïve,	
SNTR-sed	 and	 SNTR-iTR	 rats.	 Scale	 bar	 100μm.	 (C)	 Quantification	 of	 5HT2A	






























Figure	8.	Blockade	of	β2	or	5HT2A	 receptors	antagonized	 the	 iTR	 induced	hypoalgesia	











Figure	 9.	Depletion	 of	 NE	 output	 from	 locus	 coeruleus	 with	 DSP4	 did	 not	 affect	 the	
hypoalgesic	effect	of	iTR.	(A)	Changes	in	mechanical	threshold	of	SNTR-sed	and	SNTR-
iTR	groups	compared	with	rats	treated	also	with	DSP4,	recorded	at	medial	test	sites	at	


























Figure	 11.	 iTR	 reduced	microgliosis	 in	 locus	 coeruleus	 dependent	 on	 activation	 of	 β2	




colocalized	with	 Iba1.	 Scale	bar	100μm.	 (B)	Relative	quantification	of	 Iba1	and	BDNF	
immunoreactivity	 (Integrated	Density,	 InDen)	 in	 double-labeled	 LC	 samples	 of	 naïve,	
SNTR-sed	and	SNTR-iTR	rats	compared	with	rats	treated	also	with	Butoxamine	(SNTR-
sed+Bu	and	SNTR-iTR+Bu	groups).	*	p<0.05;	**	p<0.01;	***	p<0.001.		
	
	
